MYOCET 50 MG Israel - English - Ministry of Health

myocet 50 mg

medison pharma ltd - doxorubicin hydrochloride - powder,dispersion and solvent for concentrate for dispersion for infusion - doxorubicin hydrochloride 50 mg vials - doxorubicin - doxorubicin - myocet, in combination with cyclophosphamide, is indicated for the first line treatment of metastatic breast cancer in women.

Leuprorelin 1-month Depot 3.75 mg powder and solvent for prolonged-release suspension for injection Ireland - English - HPRA (Health Products Regulatory Authority)

leuprorelin 1-month depot 3.75 mg powder and solvent for prolonged-release suspension for injection

gp-pharm, s.a. - leuprorelin acetate - pdr+solv for pr for susp for inj - 3.75 milligram(s) - gonadotropin releasing hormone analogues; leuprorelin

Lutrate Depot 22.5mg powder and solvent for prolonged-release suspension for injection United Kingdom - English - myHealthbox

lutrate depot 22.5mg powder and solvent for prolonged-release suspension for injection

gp-pharm, s.a - leuprorelin acetate - powder and solvent for prolonged-release suspension for injection - 22.5mg - hormones and related agents. gonadotropin-releasing hormones analogues - it is indicated for palliative treatment of hormone dependent advanced prostate cancer.